Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$735.40M$735.40Mderived+4.0% vs Q4 2022 Net Income-$1.00M-$1.00MderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$101,400,000+7.6% Operating Cash Flowderived$62,600,000+769.4% Free Cash Flowderived$42,800,000N/M Margins · derivedOperating margin13.8%+0.5 pt vs Q4 2022
Net margin-0.1%+3.2 pt vs Q4 2022
ended Dec 31, 2023 · filed Feb 26, 2024 · 57 d after period end